• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左旋多巴对晚期帕金森病患者语速的影响

Levodopa-induced alterations in speech rate in advanced Parkinson's disease.

作者信息

De Letter Miet, Santens Patrick, De Bodt Marc, Boon Paul, Van Borsel John

机构信息

Department of Oto-Rhino-Laryngology, Center for Speech and Hearing Disorders, Gent University Hospital, Belgium.

出版信息

Acta Neurol Belg. 2006 Mar;106(1):19-22.

PMID:16776432
Abstract

The effect of speech rate on overall intelligibility in Parkinson's Disease (PD) is still a matter of debate. A comparison of the results of previous studies on speech rate in PD is hampered by methodological differences. In this study, we evaluated the effects of levodopa on speech rate and on its variability in a standardized reading task. Twenty-five patients were studied before and after levodopa administration while reading a standardized text. In accordance with previous studies, no significant improvement of speech rate was found. Rather an increased variability of speech rate in the on-medication state could be demonstrated. It is possible that this increased variability may be the consequence of respiratory deficits due to levodopa-induced dyskinesia or an increase of dysfluencies. However, the effects of defective auditory feedback and disturbed executive function cannot be ruled out.

摘要

语速对帕金森病(PD)整体可懂度的影响仍存在争议。先前关于PD语速的研究结果比较因方法学差异而受阻。在本研究中,我们在一项标准化阅读任务中评估了左旋多巴对语速及其变异性的影响。25名患者在服用左旋多巴前后阅读标准化文本时接受了研究。与先前的研究一致,未发现语速有显著改善。相反,在服药状态下可证明语速变异性增加。这种变异性增加可能是左旋多巴诱发的运动障碍导致呼吸功能缺陷或言语不流畅增加的结果。然而,听觉反馈缺陷和执行功能障碍的影响也不能排除。

相似文献

1
Levodopa-induced alterations in speech rate in advanced Parkinson's disease.左旋多巴对晚期帕金森病患者语速的影响
Acta Neurol Belg. 2006 Mar;106(1):19-22.
2
Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners.专业听众感知到的左旋多巴对晚期帕金森病患者韵律和可理解性的影响。
Clin Linguist Phon. 2007 Oct;21(10):783-91. doi: 10.1080/02699200701538181.
3
For better or worse: The effect of levodopa on speech in Parkinson's disease.不管是好是坏:左旋多巴对帕金森病患者言语的影响。
Mov Disord. 2008 Mar 15;23(4):574-80. doi: 10.1002/mds.21899.
4
The effects of levodopa on word intelligibility in Parkinson's disease.左旋多巴对帕金森病患者言语清晰度的影响。
J Commun Disord. 2005 May-Jun;38(3):187-96. doi: 10.1016/j.jcomdis.2004.09.001. Epub 2004 Nov 10.
5
The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease.左旋多巴对晚期帕金森病患者呼吸及言语清晰度的影响。
Clin Neurol Neurosurg. 2007 Jul;109(6):495-500. doi: 10.1016/j.clineuro.2007.04.003. Epub 2007 May 16.
6
Effects of Levodopa on Vowel Articulation in Patients with Parkinson's Disease.左旋多巴对帕金森病患者元音发音的影响。
Kobe J Med Sci. 2015 Apr 27;61(5):E144-54.
7
Brain dopaminergic modulation associated with executive function in Parkinson's disease.帕金森病中与执行功能相关的大脑多巴胺能调节。
Mov Disord. 2009 Oct 15;24(13):1962-9. doi: 10.1002/mds.22709.
8
Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.帕金森病患者声学语音特征与非言语运动表现之间的相关性
Med Sci Monit. 2005 Mar;11(3):CR109-16.
9
Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.特发性帕金森病中的构音障碍与病程、严重程度及左旋多巴剂量
Neurol Neurochir Pol. 2015;49(5):302-6. doi: 10.1016/j.pjnns.2015.07.002. Epub 2015 Jul 30.
10
Sequential changes in motor speech across a levodopa cycle in advanced Parkinson's disease.晚期帕金森病患者左旋多巴治疗周期中运动性言语的序贯变化。
Int J Speech Lang Pathol. 2010 Oct;12(5):405-13. doi: 10.3109/17549507.2010.491556.

引用本文的文献

1
Digital speech biomarkers can measure acute effects of levodopa in Parkinson's disease.数字语音生物标志物可测量左旋多巴对帕金森病的急性影响。
NPJ Parkinsons Dis. 2025 Jul 1;11(1):184. doi: 10.1038/s41531-025-01045-5.
2
Automatic speech analysis combined with machine learning reliably predicts the motor state in people with Parkinson's disease.自动语音分析结合机器学习能够可靠地预测帕金森病患者的运动状态。
NPJ Parkinsons Dis. 2025 May 2;11(1):105. doi: 10.1038/s41531-025-00959-4.
3
Prosody matters: Preserved prominence marking strategies in people with Parkinson's disease independent of motor status.
韵律很重要:帕金森病患者即使在不伴有运动障碍的情况下,也能保持重读标记策略。
PLoS One. 2024 Aug 20;19(8):e0308655. doi: 10.1371/journal.pone.0308655. eCollection 2024.
4
Short-term effect of dopaminergic medication on speech in early-stage Parkinson's disease.多巴胺能药物对早期帕金森病患者言语功能的短期影响。
NPJ Parkinsons Dis. 2022 Mar 7;8(1):22. doi: 10.1038/s41531-022-00286-y.
5
Speech dysfunction, cognition, and Parkinson's disease.言语障碍、认知与帕金森病。
Prog Brain Res. 2022;269(1):153-173. doi: 10.1016/bs.pbr.2022.01.017. Epub 2022 Feb 9.
6
Feedback and Feedforward Auditory-Motor Processes for Voice and Articulation in Parkinson's Disease.帕金森病语音和发音的反馈和前馈听觉-运动过程。
J Speech Lang Hear Res. 2021 Dec 13;64(12):4682-4694. doi: 10.1044/2021_JSLHR-21-00153. Epub 2021 Nov 3.
7
Speech-based characterization of dopamine replacement therapy in people with Parkinson's disease.帕金森病患者多巴胺替代疗法的语音特征分析
NPJ Parkinsons Dis. 2020 Jun 12;6:12. doi: 10.1038/s41531-020-0113-5. eCollection 2020.
8
Research-based Updates in Swallowing and Communication Dysfunction in Parkinson Disease: Implications for Evaluation and Management.帕金森病吞咽和沟通功能障碍的循证医学进展:对评估和管理的启示
Perspect ASHA Spec Interest Groups. 2019 Oct;4(5):825-841. doi: 10.1044/2019_pers-sig3-2019-0001. Epub 2019 Oct 11.
9
Intervention changes acoustic peak frequency and mesolimbic neurochemistry in the Pink1-/- rat model of Parkinson disease.干预改变帕金森病 Pink1-/- 大鼠模型的声峰频率和中脑边缘神经化学。
PLoS One. 2019 Aug 2;14(8):e0220734. doi: 10.1371/journal.pone.0220734. eCollection 2019.
10
Quantitative Analysis of Catecholamines in the Pink1 -/- Rat Model of Early-onset Parkinson's Disease.在早发性帕金森病的 Pink1 -/- 大鼠模型中儿茶酚胺的定量分析。
Neuroscience. 2018 May 21;379:126-141. doi: 10.1016/j.neuroscience.2018.02.027. Epub 2018 Feb 27.